Crescent Biopharma CBIO
NASDAQ CBIO
$14.76 +0.23 (+1.58%)
At close: Sep 29, 2026 · 4:00 PM EDT

Crescent Biopharma (CBIO) Total Current Liabilities (2013 - 2026)

Updated

Crescent Biopharma (CBIO) posted Total Current Liabilities of $18.54 million for Q2 2026, up 10.7% from $16.75 million a year earlier and up 30.6% from the prior quarter.

Analysis

Crescent Biopharma (CBIO) Total Current Liabilities (2013 - 2026) Analysis & Trends

At the end of FY2025, Crescent Biopharma's Total Current Liabilities came in at $36.07 million, up 275.2% from FY2024.

  • Annual Total Current Liabilities shows a five-year compound annual growth rate of 23.8% (FY2020 to FY2025).
  • In prior years, Crescent Biopharma's Total Current Liabilities was $9.61 million in FY2024 (+40.7%), $6.84 million in FY2023 (-23.0%), $8.88 million in FY2022 (-24.9%) and $11.82 million in FY2021 (-4.9%).
  • Quarterly Total Current Liabilities has run from a low of $2.62 million in Q1 2025 to a high of $36.07 million in Q4 2025 over five years.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last five quarters, with growth averaging 167.5% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q1 2026, with growth of 442.4%; the weakest was Q1 2025, with a decline of 50.6%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $14.19 million (Q1 2026), $36.07 million (Q4 2025) and $20.3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Crescent Biopharma 403.30 Mn -304.00 Mn - 18.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.54 Mn
Mar 31, 2026 14.19 Mn
Dec 31, 2025 36.07 Mn
Sep 30, 2025 20.30 Mn
Jun 30, 2025 16.75 Mn
Mar 31, 2025 2.62 Mn
Dec 31, 2024 9.61 Mn
Sep 30, 2024 4.32 Mn
Jun 30, 2024 4.36 Mn
Mar 31, 2024 5.29 Mn
Dec 31, 2023 6.84 Mn
Sep 30, 2023 6.39 Mn
Jun 30, 2023 6.57 Mn
Mar 31, 2023 6.74 Mn
Dec 31, 2022 8.88 Mn
Sep 30, 2022 7.75 Mn
Jun 30, 2022 8.94 Mn
Mar 31, 2022 12.78 Mn
Dec 31, 2021 11.82 Mn
Sep 30, 2021 9.66 Mn
API Access

Crescent Biopharma Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=CBIO&period=max&api_key=YOUR_API_KEY